are inherited single-gene disorders leading to production of abnormal
hemoglobin or low hemoglobin. Approximately 7% of the global population are
carriers and 2.7 per 1000 conceptions are affected by these disorders. The most
common hemoglobinopathies are Sickle cell anemia and thalassemia.
Sebia is a
market leader in manufacturing diagnostic tests for hemoglobin disorders and protein electrophoresis
. In July 2014, the company
released its Hemoglobin Atlas which is a tool to enable Sebia's capillary
electrophoresis users to orientate their diagnosis of hemoglobin disorders.
electrophoresis is an established lab method for detecting hemoglobin disorders.
Sebia's capillary electrophoresis technology allows for fast and efficient
separation of hemoglobin fractions to determine major variants of hemoglobin
and thereby aid in the detection of sickle cell or thalassemia
Atlas was released to mark the tenth successful year of this technology. The
Hemoglobin Atlas is a reference manual for hemoglobinopathies. The Atlas is
meant to enable laboratories increase their knowledge of hemoglobinopathies.
The Atlas is mainly for Sebia's capillary electrophoresis users.
counselor and collaborator, Professor Piero Giordano, Emertius professor and
clinical biochemical molecular geneticist at the Leiden University medical
center, Netherlands developed the content and research data. According to
Professor Giordano, Atlas is an interactive educational aid enabling the
tracking of as many hemoglobin variants as possible to pinpoint rare genotypes
and CEO, Benoit Adelus said that the company is focused on keeping the Altas
interactive with constant updates. He also said the company would provide
extranet access for Sebia customers.
The Hemoglobin Atlas will be updated
as and when new case studies are found. Users are also being
encouraged to contribute to the Atlas content by sharing their capillary
electrophoresis profiles with rare hemoglobin variants.
The Sebia Hemoglobin Atlas is set to be a go-to
reference guide for labs working on diagnosing hemoglobin disorders.